IRIS
DE MARTINO, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.015
NA - Nord America 2.641
EU - Europa 2.200
SA - Sud America 392
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.528
SG - Singapore 1.314
RU - Federazione Russa 1.004
CN - Cina 644
VN - Vietnam 563
IT - Italia 304
BR - Brasile 300
HK - Hong Kong 207
DE - Germania 166
FR - Francia 147
FI - Finlandia 120
NL - Olanda 117
SE - Svezia 94
CA - Canada 70
IE - Irlanda 67
IN - India 62
UA - Ucraina 52
GB - Regno Unito 43
AR - Argentina 41
JP - Giappone 35
BD - Bangladesh 28
MX - Messico 26
ZA - Sudafrica 21
ES - Italia 20
KR - Corea 17
ID - Indonesia 16
IQ - Iraq 16
PH - Filippine 16
TH - Thailandia 16
TR - Turchia 15
PL - Polonia 14
MA - Marocco 13
EC - Ecuador 12
AT - Austria 11
CI - Costa d'Avorio 11
IR - Iran 10
VE - Venezuela 10
PY - Paraguay 8
SA - Arabia Saudita 8
CO - Colombia 7
CZ - Repubblica Ceca 7
KE - Kenya 7
PK - Pakistan 7
DO - Repubblica Dominicana 6
JO - Giordania 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
ET - Etiopia 5
LT - Lituania 5
UY - Uruguay 5
UZ - Uzbekistan 5
HN - Honduras 4
RO - Romania 4
BE - Belgio 3
CH - Svizzera 3
DZ - Algeria 3
LB - Libano 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
LY - Libia 2
MC - Monaco 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
RW - Ruanda 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
IM - Isola di Man 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MD - Moldavia 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 8.322
Salva come PNG Salva come JPEG
Città #
Singapore 619
San Jose 496
Chandler 258
Moscow 253
Hong Kong 202
Ashburn 196
Beijing 185
Ho Chi Minh City 175
Hanoi 143
Amsterdam 102
Hefei 91
The Dalles 82
Munich 81
Naples 74
Millbury 70
Santa Clara 66
Los Angeles 59
Lauterbourg 56
Princeton 54
Jacksonville 53
Nanjing 46
Buffalo 43
Wilmington 43
Helsinki 42
New York 42
Boston 36
Da Nang 32
Napoli 31
Ottawa 29
Tokyo 28
São Paulo 27
Redondo Beach 25
Turku 24
Houston 22
Orem 22
Des Moines 20
Falls Church 19
Seattle 19
Frankfurt am Main 16
Woodbridge 16
Mexico City 15
Dallas 14
Montreal 14
Seoul 14
Chicago 13
Council Bluffs 13
Hebei 13
Atlanta 12
Johannesburg 12
Nanchang 12
San Mateo 12
Toronto 12
Warsaw 12
Biên Hòa 11
Chennai 11
Phoenix 11
Stockholm 11
Brooklyn 10
Denver 10
Haiphong 10
Kochi 10
London 10
Rio de Janeiro 10
San Francisco 10
Lawrence 9
Milan 9
Poplar 9
Portici 9
Shenyang 9
Afragola 8
Boardman 8
Falkenstein 8
Nuremberg 8
Pescara 8
Ankara 7
Belo Horizonte 7
Curitiba 7
Dearborn 7
Dublin 7
Nairobi 7
Rome 7
Thái Bình 7
Ardabil 6
Asunción 6
Bangkok 6
Bologna 6
Catania 6
Changsha 6
Kronberg 6
Pune 6
Tianjin 6
Vienna 6
Addis Ababa 5
Amman 5
Baghdad 5
Can Tho 5
Charlotte 5
Guayaquil 5
Hải Dương 5
Marigliano 5
Totale 4.420
Salva come PNG Salva come JPEG
Nome #
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 179
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 178
Effect of the acute administration of the Dopamine Agonist Cabergoline on glucose tolerance and Insuline Sensitivity in patient with obesity. 176
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 161
Neuropsychiatric disorders in Cushing's syndrome. 154
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 152
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 152
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 150
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 147
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 147
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 143
Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors. 142
Severe systemic complications of acromegaly 141
Pathophysiology of diabetes mellitus in Cushing's syndrome. 141
Cushing's syndrome: aftermath of the cure. 139
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 139
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 138
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 138
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 138
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials 138
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 137
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 133
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 131
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 131
Metabolic alterations and cardiovascular outcomes of cortisol excess 131
Valutazione dell’efficacia della terapia adiuvante con mitotane nel carcinoma corticosurrenalico localizzato con rischio di recidiva basso-moderato (Studio ADIUVO) 128
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 128
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. 124
Cushing's syndrome 122
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 121
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery 121
Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting 121
Cushing’s disease: the burden of illness 119
The treatment with pasireotide in Cushing’s disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center 119
Cardiovascular disease in Cushing's syndrome: heart versus vasculature. 118
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 118
Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia 117
Genetic Heterogeneity in Adrenal Insufficiency 117
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. 117
The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states 116
Is mortality in Cushing's disease reversible with remission? 114
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 114
New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours 113
Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration 112
Treatment with GH receptor antagonist in acromegaly:effect on cardiac arrhythmias. 108
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors. 108
The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets. 107
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma 105
The role of somatostatin receptors in the medical treatment of acromegaly 104
Erratum to: Pituitary tumors and pregnancy: The interplay between a pathologic condition and a physiologic status (Journal of Endocrinological Investigation (2014) 37, (99-112) DOI: 10.1007/s40618-013-0019-8) 104
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance 103
The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs 102
TREATMENT WITH GROWTH HORMONE RECEPTOR ANTAGONIST IN ACROMEGALY: EFFECT ON CARDIAC ARRHYTHMIAS. 101
Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors. 97
Role of the mTOR pathway in normal and tumoral adrenal cells. 96
Il sistema di stratificazione S-GRAS per la classificazione prognostica del carcinoma surrenalico 95
The role of mTOR pathway as target for treatment in adrenocortical cancer 89
Clinical Case 1 86
Comment on Azmahani et al. "Steroidogenic enzymes, their related transcription factors and nuclear receptors in human sebaceous glands under normal and pathological conditions" 83
Complications of Cushing's syndrome: State of the art 80
Paediatric Cushing’s disease: Epidemiology, pathogenesis, clinical management and outcome 73
IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer 73
Global epidemiology of acromegaly: a systematic review and meta-analysis 68
The dopaminergic control of Cushing's syndrome 68
Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells 67
Six controversial issues on subclinical Cushing’s syndrome 67
Abnormal linear growth in paediatric adrenal diseases: Pathogenesis, prevalence and management 66
Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims database to identify acromegaly as a model for the earlier diagnosis of rare diseases 64
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer. 60
The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells. 58
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 56
Somatostatin and somatostatin receptors: from basic concepts to clinical applications. 52
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 50
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 49
How should patients with adrenal incidentalomas be followed up? 45
Adrenal causes of endocrine hypertension in childhood or adolescence 34
Sexual Dysfunctions Associated with Proton Pump Inhibitors: Insights from VigiBase, the World Health Organization Pharmacovigilance Database 5
Multicentric Retrospective Analysis of Oncocytic Adrenocortical Carcinoma: Insights into Clinical and Management Strategies 5
Characteristic of Aldosterone-Producing adrenocortical carcinoma: review of the literature 3
Totale 8.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 54 2
2021/2022439 6 3 3 5 19 49 9 12 74 28 90 141
2022/2023610 65 42 12 59 81 69 4 57 89 105 16 11
2023/2024302 15 49 42 22 9 18 12 33 7 9 46 40
2024/20252.140 84 104 31 17 28 121 270 135 113 200 857 180
2025/20264.228 478 290 436 415 784 164 526 215 515 287 118 0
Totale 8.446